Nerve Regeneration Market Assessment and Professional Application Scope Shared In Detailed Report, Forecast 2023
Nerve Regeneration Market Research by Product, (Neurostimulation & Neuromodulation Devices and Biomaterials), by Application, (Neurostimulation and Neuromodulation Surgeries, Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy and others), by End User (Hospitals & Clinics, Ambulatory Surgery Centers and others) and Regional Size, Growth Analysis, Technology Enhancements and Trends – Forecast till 2024.
Neuroregeneration or nerve regeneration refers to the process of repair and regrowth of injured nerve tissues, cells, and cell products. Investments in research and development are likely to boost the market demand significantly. For instance, Polyganics has established a new unit at the Zernike Campus, Netherlands for expanding their R&D unit.
The Global Nerve Regeneration Market Size is Expected to register 11.34% CAGR To reach USD 12695.25 Million by 2024.
Request For a FREE Sample@ https://www.marketresearchfuture.com/sample_request/1202
Surgeries to embed neurostimulation devices, as well as ongoing developments of a brain computer interface, can influence the market in the coming years. Advances in neuroimaging and neurostimulation which can provide relief to patients, can drive the market demand significantly.
Market Key Players
Collaborations, product launches, and technological breakthroughs are certain strategies that can influence players in the market.
Boston Scientific Corporation, Medtronic, Integra LifeSciences, Abbott, Axogen Corporation, LivaNova PLC, Nuvectra Corporation, Stryker Corporation, Polyganics, and NeuroPace are key players in the global nerve regeneration market.
Primary end users of the global nerve regeneration market include hospitals & clinics, ambulatory surgery centers, and others.
13 LIST OF FIGURES
FIGURE 1 GLOBAL NERVE REGENERATION MARKET: MARKET STRUCTURE
FIGURE 2 RESEARCH PROCESS OF MRFR
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL NERVE REGENERATION MARKET
FIGURE 5 VALUE CHAIN: GLOBAL NERVE REGENERATION MARKET
FIGURE 6 PORTER’S FIVE FORCES ANALYSIS OF THE GLOBAL NERVE REGENERATION MARKET
FIGURE 7 GLOBAL NERVE REGENERATION MARKET, BY PRODUCT, 2018 & 2024 (USD MILLION)
FIGURE 8 GLOBAL NERVE REGENERATION MARKET, BY APPLICATION, 2018 & 2024 (USD MILLION)
FIGURE 9 GLOBAL NERVE REGENERATION MARKET, BY END USER, 2018 & 2024 (USD MILLION)
FIGURE 10 GLOBAL NERVE REGENERATION MARKET, BY REGION, 2018 & 2024 (USD MILLION)
FIGURE 11 AMERICAS: NERVE REGENERATION MARKET SHARE, BY REGION, 2018 (%)
FIGURE 12 EUROPE: NERVE REGENERATION MARKET SHARE, BY REGION, 2018 (%)
FIGURE 13 ASIA–PACIFIC: NERVE REGENERATION MARKET SHARE, BY COUNTRY, 2018 (%)
FIGURE 14 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET SHARE, BY REGION, 2018 (%)
FIGURE 15 GLOBAL NERVE REGENERATION MARKET COMPANY SHARE ANALYSIS, 2018 (%)
Continued…
Browse Complete Premium Report Details of “Nerve Regeneration Market Research Report – Global Forecast till 2024” at: https://www.marketresearchfuture.com/reports/nerve-regeneration-market-1202
MRFR segments the global nerve regeneration market on the basis of regions into Europe, the Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA).
Market Segmentation
The global nerve regeneration market has been segmented on the basis of product, application, and end user.
Based on product, the market has been segregated into neurostimulation & neuromodulation devices and biomaterials. On the basis of neurostimulation and neuromodulation devices, the market has been divided into internal neurostimulation devices and external neurostimulation devices. Internal neurostimulation devices has been further segmented into vagus nerve stimulation, spinal cord stimulation, sacral nerve stimulation, deep brain stimulation, and gastric electrical stimulation. External neurostimulation devices cover transcutaneous electrical nerve stimulation and transcranial magnetic stimulation. Nerve conduits, nerve wraps, nerve protectors, and nerve connectors are segments encompassed within the biomaterials segment. Among them, the neurostimulation and neuromodulation devices segment was valued at USD 4,764.96 million in 2018. Large number of movement disorders and need for such tools for their treatment can drive the segment growth.
Major market applications include neurostimulation and neuromodulation surgeries, nerve grafting, stem cell therapy, direct nerve repair/neurorrhaphy, and others. Neurostimulation and neuromodulation surgeries have been further segmented into internal neurostimulation and neuromodulation surgeries, external neurostimulation, and neuromodulation surgeries. Nerve grafting encompasses autografts, allografts, and xenografts.
Avail an Amazing Discount at: https://www.marketresearchfuture.com/check-discount/1202
For instance, NervGen Pharma recently decided to collaborate with Case Western Reserve University for rapidly bringing to market a new technology capable of treating patients with spinal cord injury. The use of proprietary agents termed as ISP can be used to impede the signals of protein tyrosine phosphatase (PTP), a key component that inhibits nerve regeneration.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Comments
Post a Comment